Senior Director, Payer Accounts

Who We Are:

Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's.

The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.

Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.

The Role:

The Senior Director, Payer Accounts is a field-based positionresponsible for managing a team of Account Directors focused on gaining and maintaining broad coverage and access for Cogent’s products. This individual will be responsible for building and maintaining relationships with key stakeholders including regional payers, pharmacy benefit managers (PBMs), MACs and state Medicaid agencies. They will collaborate extensively with internal departments and functions to incorporate customer insights into pricing, contracting and market access strategies including Marketing, Sales, and Sales Operations, Patient Services, and Legal.

Responsibilities:

• Lead payer team to develop and implement strategies to maximize product access.

• Establish and maintain relationships with key decision makers, including medical and pharmacy directors.

• Negotiate and execute contracts with assigned targeted accounts, help provide access for clinical and/or economic discussions.

• Ability to articulate the value proposition of Cogent’s products to appropriate customers.

• Collaborate and align on pricing & contracting strategies, HEOR evidence generation plans and payer marketing initiatives.

• Work with multiple stakeholders across internal divisions (Sales, Contract & Pricing, Medical, Trade, Legal/Compliance and Marketing) and serve as the main point of contact for account and decision making.

• Formulate, implement, and regularly assess business plan with internal team members to achieve business objectives and utilize all available resources to maximize product & patient access.

• Adhere to relevant regulatory and compliance guidelines and Company policies.

• Attend and participate in meetings and/or conferences as requested by management.

Qualifications:

• Bachelor’s degree required, MBA or other advanced degree preferred.

• 10-12+ years of pharmaceutical industry experience with at least 8 in market access account management and/or leadership.

• Demonstrated success in engaging with US Payers, including PBM’s, state Medicaid agencies etc.

• Strong abilities in communication and presentation skills.

• Skilled in strategic thinking, leadership negotiation and relationship management.

• Ability to travel up to 50%.

Salary Range:

240,000 - 280,000 $USD

Target Bonus: 25%

Exact compensation will vary based on skills, experience, and location.

Our Locations

Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on-site parking and gym facilities in the building.

Boulder, CO: We have just moved into our new state-of-the art Research Facility in the fast-growing biopharmaceutical hub in the greater Denver/Boulder corridor. Our CEO is based full-time in this location and we are proud to call this the home of Cogent’s discovery research organization.

Our Offer To You

To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits.

We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.